Army Withholds Chemical-Attack Antidote From
First Responders
Reactive Skin Decontamination
Lotion Undergoes Testing By Army
POSTED:
10:13 am EDT June 11, 2004
WASHINGTON -- A New York City police department physician
thinks she has found a promising antidote for emergency workers to use if
terrorists launch a chemical weapons attack, but the federal government won't
let the city buy it -- even though the U.S. Army can.
The product, Reactive Skin Decontamination Lotion, was developed by the Canadian
military years ago, won Food and Drug Administration approval in 2003 and
is sold in other NATO countries for neutralizing sarin, mustard gas and other
chemical agents.
It is being tested by the Army. But the companies that make it aren't permitted
to sell it or even advertise it to state and local governments in the United
States. "Right now, they have no product to decontaminate people other
than soap and water," said Phil O'Dell, president of O'Dell Engineering,
a Canadian-based company licensed by the Canadian government to sell the
lotion. "There is only one FDA-approved. It's the RSDL.
These first responders correctly have been trying to buy RSDL since FDA approval."
Dr. Dani Zavasky, deputy medical director for the New York Police Department's
counterterrorism bureau, thinks the antidote is promising and wonders why
her agency cannot buy it. As described by the FDA at the time it approved
it for the Army in April 2003, a lotion-soaked sponge is packaged in a special
foil pouch that people can carry, ready to rip open and wipe on any exposed
skin as soon as possible after exposure to a chemical attack.
"I'm not aware of any substance other than
this out there that has been used for so long by others that has this benefit."
Dr. Dani Zavasky,
New York Police Department Zavasky said she heard about the antidote
from Marines, not from the Army or the Homeland Security Department, whose
duties include tipping off state and local governments to new anti-terrorism
technologies.
Frustrated by the delay, O'Dell Engineering and its U.S. business partner,
New York state-based E-Z-EM Inc., have started lobbying lawmakers and the
Army."I'm not aware of any substance other than this out there that has been
used for so long by others that has this benefit," Zavasky said. "I've been
hearing about it for a year and a half now and still it's not widely available."
The Army says it wants to do more testing on issues such as whether the lotion
is safe to use with bleach, before it making it standard issue for its troops
or letting police, firefighters and other first responders buy it. "The
manufacturer will have to be patient. Until the compatibility with bleach
solutions is determined and can be clearly defined, we can't field it," said
Maj. Gary Tallman, an Army spokesman. "It wouldn't be proper to field it
to our war fighters and our first responders."
In the United States, the Army rather than O'Dell Engineering obtained the
FDA's approval, meaning O'Dell cannot sell it to state and local governments
without Army permission. But that doesn't preclude other federal agencies
from trying to bring the drug to first responders. Homeland Security
Department spokesman Kirk Whitworth said the agency doesn't comment on specific
products but is "committed as a department to speeding the access to the
most effective products available."
"The companies are all part of the group that are approaching their members
of Congress, number one to educate them about this issue and number two to
give them their spin on it and basically say if we don't produce this in
the United States, they're going to produce this overseas," said James Albertine,
a Washington lobbyist coordinating the campaign.
The lobbying is paying off: At least two Republicans whose constituents include
companies involved in the making of RSDL -- Pennsylvania Sen. Rick Santorum
and New York Rep. John Sweeney -- have written the Army. The Army could
be at least two years away from buying RSDL in significant quantities.
That time lag could force companies that make RSDL ingredients to shut down
or scale back their assembly lines, raising RSDL's cost or making it hard
to produce large quantities quickly, said Tony Lombardo, chief executive
of E-Z-EM, a health care company involved with the lotion. Lombardo
estimates the product, packaged in a pouch that can treat one person, would
cost roughly $20 to $22 per pouch.
E-Z-EM and O'Dell Engineering said the product has been used safely in several
countries, including NATO allies, for years and that they are considering
seeking FDA approval themselves to market the lotion to first responders.
J.R. Thomas, director of the Franklin County Emergency Management Agency
in Columbus, Ohio, past president of the International Association of Emergency
Managers, said he wasn't aware of RSDL. "That's one of our big beefs
as local emergency management people, is we need to make sure there's a good
wave of communication between the federal government, the states and the locals,"
Thomas said. "Not only policy but also these materials that are coming through
the pipeline. Because we don't know what's good and what's bad."
Fire Chief Joe Wallin of Minnetonka, Minn., a Minneapolis suburb, said he
too never heard of RSDL, but questions whether many communities would buy
it when soap and water can remove chemical agents from many people.
The NYPD's Zavasky said that while removing contaminated clothes and using
soap and water works, the lotion would be useful after showering to neutralize
any chemical agent that penetrated the skin.